INTRODUCTION
Understanding the molecular mechanisms linking adipose tissue to obesity-related pathologies such as type 2 diabetes, hypertension or coronary heart disease is both scientifically and medically relevant. Cells in adipose tissue produce a variety of adipokines, which have effects on insulin sensitivity (IS), glucose and lipid levels as well as on satiety and appetite. 1 Recently, vaspin (visceral adipose tissue-derived serine protease inhibitor; serpinA12) was identified as a member of the serine protease inhibitor family with insulin-sensitizing effects, which was expressed in visceral adipose tissue of a rat model of type 2 diabetes. 2 Owing to structural similarity, a serpin function has been hypothesized for vaspin, but the precise mechanism of vaspin action on the molecular level remains unknown.
Increased vaspin mRNA expression in human adipose tissue has been shown to be associated with obesity, insulin resistance (IR) and type 2 diabetes. 3 Likewise elevated serum vaspin concentrations correlate with obesity and impaired IS in humans. 4 Administration of vaspin to mice with diet-induced obesity improved glucose tolerance as well as IS and altered gene expression of candidate genes for IR. This raised the hypothesis that vaspin administration reverses the expression of genes related to IR. 2 It has therefore been postulated that increased vaspin expression and secretion may represent a compensatory mechanism associated with obesity, severe IR and type 2 diabetes. In addition, circulating vaspin levels follow a meal-related diurnal variation in humans similar to that of ghrelin, suggesting a previously unrecognized role of vaspin in the regulation of food intake. 5 Recently, we showed that intracerebroventricular administration of vaspin in mice resulted in reduced fasting blood glucose further supporting the role of vaspin in central regulation of the metabolism. 6 Here, we hypothesized that variability in serum vaspin concentrations has genetic components. First, we conducted a genomewide association study (GWAS) for serum vaspin in the Sorbs cohort (N ¼ 826). The vaspin gene mapped within the most promising association locus from the GWAS. Therefore, given both the chromosomal location and the physiological plausibility of the vaspin locus, we genotyped 26 single-nucleotide polymorphisms (SNPs) covering genetic variation in the vaspin gene in the Sorbs. In addition, we measured serum vaspin concentrations in 1806 samples from Augsburg/the Cooperative Health Research in the Region of Augsburg (KORA) for replication of the association signals. Finally, we conducted association analyses of vaspin SNPs with metabolic traits in the Sorbs, KORA and a further cohort from Germany (Leipzig: N ¼ 1857).
The study provides strong evidence for the role of genetic variants in the vaspin gene in regulating circulating serum vaspin concentrations.
MATERIALS AND METHODS

Ethic statement
The studies were approved by the Ethics Committee of the University of Leipzig, and all individuals gave written informed consent before taking part in the study. All study participants included in the KORA cohort gave informed written consent and the study was approved by the Ethic Committee of the Bavarian Medical Association.
Subjects
Sorbs cohort. The cohort has recently been recruited from the selfcontained Sorbs population in Germany. [7] [8] [9] Extensive phenotyping included standardized questionnaires for past medical history and family history, collection of anthropometric data (weight, height, waist-to-hip ratio), and an oral glucose tolerance test. In all, 907 Sorbs without and 106 with type 2 diabetes were included in the study. Based on oral glucose tolerance test in the healthy subjects (no established type 2 diabetes), 786 (311 male, 475 female) had normal glucose tolerance (mean age 44±15 years, mean body mass index (BMI) 25.9±4.3 kg m À 2 ) and 121 (52 male, 69 female) subjects had impaired glucose tolerance (mean age 59 ± 12 years, mean BMI 30.3 ± 5.0 kg m À 2 ). The 106 patients with type 2 diabetes (46 male, 60 female) were 63 ± 11 years old and had a mean BMI of 31.0 ± 5.5 kg m À 2 (diabetes definition according to the ADA criteria from 2010; 10 data given as arithmetic means±s.d.; Supplemental Table S1 ).
Leipzig cohort. Individuals included in the Leipzig cohort have been recruited at the University Hospital in Leipzig (Germany). Extensive metabolic phenotyping including oral glucose tolerance test and fasting plasma insulin measurements was performed in all subjects without diabetes as described previously. 11 Furthermore, in a subgroup of 423 healthy subjects, hyperinsulinemic-euglycemic clamps were done to assess IS. 12 This study included 1857 individuals: 233 male and 506 female subjects with normal glucose tolerance (mean age 49 ± 14 years, mean BMI 28.1 ± 5.5 kg m À 2 ). The subgroup of subjects with impaired glucose tolerance included 71 men and 109 women with a mean age of 51±12 years, mean BMI 30.4±5.6 kg m À 2 . In total, 938 (484 male and 454 female) out of 1857 subjects had type 2 diabetes (mean age 64±11 years, mean BMI 29.6 ± 5.2 kg m À 2 ; data given as arithmetic means ± s.d.; Supplemental Table S1 ).
KORA cohort. The KORA 13 survey F4 contains 1813 subjects with available genome-wide genotyping data on which the 1646 included nondiabetic subjects (792 men and 854 women) have a mean age of 60±9 years and an average BMI of 27.8±4.6 kg m À 2 . The 91 male and 76 female subjects with type 2 diabetes show a mean age of 67 ± 7 years and their mean BMI is 31.6 ± 5.6 kg m À 2 (data given as arithmetic means ± s.d.; Supplemental Table S1 ).
Measurement of serum vaspin
Blood samples were taken in the morning after an overnight fast, and serum and plasma were separated by centrifugation. Serum vaspin concentrations were measured using a commercial enzyme-linked immunosorbent assay kit (AdipoGen, Seoul, Korea) according to the manufacturer's protocol. 4 The assay has a sensitivity of 12 pg ml À 1 and the intra-and inter-assay coefficients of variance were 1.3-3.8% and 3.3-9.1%, respectively. Vaspin concentrations were determined in serum samples from 1046 Sorbs and 1806 samples from the KORA cohort.
GWAS for serum vaspin in the Sorbs
Genotyping was performed using the 500-K Affymetrix GeneChip and the Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Inc., Santa Clara, CA, USA) by the Microarray Core Facility of the Interdisciplinary Center for Clinical Research, University of Leipzig, Germany and by ATLAS Biolabs GmbH, Berlin, Germany, as described in detail elsewhere. 7 SNPs fulfilling the following criteria were included in the analyses: missing rate per SNP 5%, the Hardy-Weinberg equilibrium P40.0001, minor allele frequency40.01. The average genotyping rate was 99.0%. In total, 390619 autosomal markers overlapping between the 500-K Affymetrix GeneChip and the Affymetrix Genome-Wide Human SNP Array 6.0 were included in the analyses.
Genotyping of vaspin SNPs
Genotyping of 26 representative SNPs ( Figure 1 ) in the Sorbs and Leipzig cohort was done by using the KASPar assay system according to the manufacturer's protocol (KBioscience Ltd, Hoddesdon, UK) and by using the ABI PRISM 7500 Sequence Detecting System (Life technologies, Foster City, CA, USA). To assess genotyping reproducibility, a random B5% selection of sample was re-genotyped for all SNPs; all genotypes matched initial designated genotypes. Genotypes of the KORA F4 samples were extracted from the previously reported data generated by using the Affymetrix Human SNP Array 6.0 and imputed with IMPUTE v0.4.2 14 based on HapMap Phase II. We included 1813 randomly selected participants of KORA F4 in this study. 13 
Statistical analyses
Call rates per sample were checked using the GeneChip Genotyping Analysis Software (GTYPE) (Affymetrix, Inc.). The calculation of minor allele frequency, Hardy-Weinberg equilibrium and missing rates per SNP was performed with PLINK 15 as described in detail elsewhere. 7 Genome-wide association with serum vaspin was assessed by linear regression in PLINK (additive model). We corrected for age, gender, BMI and for relatedness by using genomic control (l ¼ 1.18).
Based on anthropometric and oral glucose tolerance test measurements, various indices of IR/IS and insulin secretion were calculated (for formula see Supplemental Table S2) .
Before statistical analysis, non-normally distributed variables were logarithmically transformed to approximate normal distribution. Genotype Figure 1 . Schematic representation of the vaspin gene and genotype variants. Reference NCBI NM_173850 and Ensembl ENSG00000165953. In total, 26 tagging polymorphisms extracted from the HapMap database (http://www.hapmap.org) were selected for further investigation. These 26 SNPs were representative for their linkage disequilibrium groups and therefore genotyped in German Caucasians for association studies with type 2 diabetes and related traits.
frequencies between diabetic cases and healthy controls were compared by logistic regression analyses. Linear regression models have been used to assess the relationship between SNPs and quantitative traits. All analyses were done under the additive model (with genotypes coded to a continuous numeric variable) and the presented P-values are adjusted for age, gender and BMI (except for obesity traits). P-values o0.05 but not reaching statistical significance levels after the Bonferroni correction for multiple testing (Po0.002 considering 26 tested variants) were considered to be of nominal statistical significance. All P-values are provided without the Bonferroni correction. Effect directions were standardized to the positive strand and the minor allele.
Association analyses on quantitative traits were restricted to subjects without type 2 diabetes to avoid influence of diabetes status or treatment on potential effects of vaspin variants on these traits.
Combined analyses including various study cohorts were performed as a weighted meta-analysis by using the METAL software based on the sample size and the P-values of each study. 16 The meta-analysis was run in a fixed effects model by using the Stouffer method. 17 Statistical analyses were done using the PASW statistics 18 version 18.0.1 (SPSS, Inc.; Chicago, IL, USA) and the statistical program R. 18 
RESULTS
GWAS for serum vaspin concentrations
We examined the distribution of test statistics and the deviation from the expected distribution under the null hypothesis of no Figures 2a-b) . The best hit mapped to the intergenic region between vaspin and serpinA4 (rs11160190, P ¼ 2.4 Â 10 À 15 ), one SNP is located directly in vaspin (rs6575436, P ¼ 2.1 Â 10 À 8 ), four polymorphisms are downstream of vaspin (rs4905203, rs1956713, rs1956721) whereas one of these SNPs mapped downstream of serpinA11, in the intergenic region to serpinA1 (rs11621467; Figure 2c ). These associations were confirmed by in silico replication in the KORA cohort with P-values ranging from 3.2 Â 10 À 5 for rs11621467 to 1.8 Â 10
À 27 for rs11160190 (Table 1) .
Meta-analysis of the six best association signals from the Sorbs study. In line with the initial GWAS, rs11160190 reached the lowest P-value in the meta-analysis (P ¼ 3.8 Â 10 À 41 ). This SNP was then followed by rs6575436 (P ¼ 1.8 Â 10 À 20 ) located within the vaspin locus, followed by rs1956721 (P ¼ 7.0 Â 10 À 16 ), rs1956713 (P ¼ 2.5 Â 10 À 16 ), rs4905203 (P ¼ 4.4 Â 10 À 13 ) and rs11621467 (P ¼ 5.1 Â 10 À 12 ; Table 1 ).
Fine mapping/genetic variation in the vaspin gene Based on the GWAS and as the vaspin gene represents a plausible physiological candidate gene, 26 tagging SNPs were extracted from the HapMap Phase II database (http://www.hapmap.org) using the Tagger software 19 according to a minor allele frequency40.05 and r 2 40.8. These 26 HapMap tagging SNPs covered 100% of the variation in the vaspin locus and were genotyped in the Sorbs and Leipzig cohort as described in the Materials and methods section (Figure 1) .
We calculated the Hardy-Weinberg equilibrium for each SNP in all cohorts. In the Leipzig cohort one SNP (rs8015166) and in the KORA cohort two SNPs (rs11625941 and rs4905211) deviated from the Hardy-Weinberg equilibrium (all Po0.001).
Vaspin genetic variants and association with serum vaspin Several SNPs in the vaspin gene were significantly associated with serum vaspin concentrations in the Sorbs. Associations of 5 SNP ranged from P ¼ 10 À 8 to 10 À 12 , which would withstand a threshold for genome-wide significance (Table 2 and Supplemental Table S3d) .
Consistent with the Sorbs data, multiple SNPs were significantly associated with serum vaspin concentrations in the KORA cohort, reaching maximal P-values of 10 À 25 ( Table 2 ). In a combined analysis including both the Sorbs and the KORA cohorts, associations of seven SNPs reached P-values between 10 À 8 and 10
À 35 ( Figure 3 , Table 2 ).
Case-control studies for type 2 diabetes In a case-controlcontrol study including 786 Sorbian subjects with normal glucose tolerance and 106 subjects with type 2 diabetes, 1 SNP (rs10145558) was nominally associated with diabetes (P ¼ 0.04 after adjusting for age, gender and BMI). In a casecontrol study in the Leipzig cohort, including 739 subjects with normal glucose tolerance and 938 subjects with type 2 diabetes, rs11625941 was nominally associated with type 2 diabetes (P ¼ 0.006 after adjusting for age, gender and BMI). None of these associations would withstand adjustments for multiple testing in the statistical analyses. Also, there was no association with type 2 diabetes in a case-control study in the KORA cohort (1646 nondiabetic subjects vs 167 subjects with type 2 diabetes; Supplemental Table S4 ).
Finally, meta-analysis including all the three cohorts (Sorbs, Leipzig and KORA) did not show any association between the analyzed SNPs and type 2 diabetes (data not shown).
Association of genetic variants in vaspin with quantitative traits Although multiple vaspin SNPs were nominally associated with quantitative traits and calculated indices of IS and secretion in analyses including 907 nondiabetic Sorbs, 919 nondiabetic subjects of the Leipzig and 1646 subjects of the KORA cohorts, none of them would withstand adjustments for multiple testing in the statistical analyses (Supplemental Tables S3 and 5) .
Meta-analysis with quantitative traits. All SNPs showing associations with serum vaspin concentrations with Po10 À 8 in the metaanalysis were included in the meta-analysis of the quantitative traits. None of the included SNPs was associated with any of the analyzed traits (Supplemental Table S6 ).
DISCUSSION
Vaspin as an adipokine has been identified in visceral white adipose tissue of the OLETF rat, 2 an animal model of abdominal obesity and type 2 diabetes. 20 It has been postulated that vaspin might have insulin-sensitizing effects 2, 21 and therefore represent a compensatory factor against insulin resistance.
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In this study, we hypothesized that genetic determinants could explain the variability in serum vaspin concentrations. Using a GWAS, we showed that polymorphisms on chromosome 14 were associated with serum vaspin concentrations. As these SNPs map to a genomic region including the vaspin locus and as the vaspin gene represents a plausible physiological candidate, we further hypothesized that the variability in serum vaspin levels might be directly affected by genetic variation in vaspin.
Indeed, this was supported by fine mapping including the HapMap tagging SNPs covering common genetic variation in the gene and by subsequent association analyses with circulating vaspin concentrations.
Although numerous studies on vaspin have been reported, to our knowledge, this study providing a GWAS in the Sorbs and serum vaspin measurements in 2852 subjects is the largest one addressing the role of genetics in the regulation of serum vaspin concentrations.
We identified several polymorphisms on chromosome 14 in the region including vaspin and tested associations with traits related to the metabolic syndrome. Our results show that genetic variants in the vaspin gene are strongly associated with serum vaspin concentrations. It is also noteworthy that the A-allele of the vaspin SNP rs2236242 previously reported to be associated with type 2 diabetes in a German population 23 correlated with higher waist circumference, waist-to-hip ratio, fasting and 30 min glucose levels, area under curve for glucose, homeostasis model assessment for IR, and with lower fasting Belfiore, quantitative IS check index and Stumvoll insulin-sensitivity index in the Sorbs. However, although several SNPs were strongly associated with serum vaspin in our study, none of the nominal SNP associations with type 2 diabetes or related metabolic traits would withstand corrections for multiple testing (for example, Bonferroni).
Therefore, it appears difficult to speculate whether the moderate SNP effects on type 2 diabetes and related traits could be mediated by their effects on serum vaspin concentrations. However, we are aware that given the relatively small sample sizes and thus limited statistical power, we may have missed associations with type 2 diabetes and relevant traits. Nevertheless, we followed the association signals from our GWAS for vaspin and looked up the associations between vaspin SNPs and quantitative traits related to type 2 diabetes in recently published large-scale association studies (http://geneticassociationdb.nih.gov/cgi-bin/index.cgi). Consistent with our data, none of the vaspin SNPs showed statistically significant associations with type 2 diabetes or relevant traits (fasting glucose and insulin, 2 h glucose, HbA1c, homeostasis model assessment of insulin resistance and homeostasis model assessment of beta-cell function). For instance, out of the six best hits found in our GWAS on serum vaspin, the 'strongest' association signals in the MAGIC study were observed for rs4905203 and rs11621467 with fasting glucose (P ¼ 0.03) and for HbA1c with rs4905203 (P ¼ 0.045; NB46 000). [24] [25] [26] Given the genome-wide nature of these data including the multiple testing problems, none of these associations can be considered statistically significant. Furthermore, it has to be mentioned that in the light of very subtle correlations between serum vaspin and the metabolically relevant traits, the lack of associations between SNPs and quantitative traits may not be surprising at all. At the same time this indicates that our knowledge of vaspin biology and particularly its role in the pathophysiology of IR is still very poor and warrants further extensive investigations.
Finally, it has to be acknowledged that the SNP rs11160190 showing strongest association with circulating vaspin in the GWAS, maps 5 0 upstream of vaspin and may therefore be involved in the transcriptional regulation of the gene. According to the Transcription Element Search System (http://www.cbil.upenn.edu/ tess) and PROMO (http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/ promoinit.cgi?dirDB=TF_8.3), the SNP is located within various potential binding sites for transcription factor such as neurofibromatosis type-1 and TFII-I for the major G-allele and vitamin D receptor , FOXP3, PXR-1, c-Myb and GR for the minor A-allele. Undoubtedly, functional experiments addressing the effects of the SNP on transcription of vaspin will be inevitable to prove the causality of this variant.
Nevertheless, our data provide strong evidence that genetic variants in the vaspin gene might explain the variability in serum vaspin concentrations. 
